Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,000 | 1 | 44.6% |
| Consulting Fee | $9,600 | 1 | 38.9% |
| Travel and Lodging | $2,133 | 4 | 8.6% |
| Food and Beverage | $1,772 | 85 | 7.2% |
| Education | $99.95 | 1 | 0.4% |
| Gift | $71.52 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $13,317 | 10 | $0 (2018) |
| INTERCEPT PHARMACEUTICALS, INC. | $9,600 | 1 | $0 (2020) |
| Janssen Biotech, Inc. | $590.00 | 24 | $0 (2023) |
| ABBVIE INC. | $466.64 | 23 | $0 (2024) |
| PFIZER INC. | $243.63 | 15 | $0 (2024) |
| Celgene Corporation | $95.65 | 6 | $0 (2024) |
| Braintree Laboratories, Inc. | $71.52 | 1 | $0 (2021) |
| Amgen Inc. | $51.77 | 2 | $0 (2022) |
| Romark Laboratories, LC | $39.39 | 2 | $0 (2019) |
| Boston Scientific Corporation | $37.48 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $224.00 | 11 | ABBVIE INC. ($100.71) |
| 2023 | $328.20 | 13 | Janssen Biotech, Inc. ($197.73) |
| 2022 | $605.28 | 33 | ABBVIE INC. ($216.47) |
| 2021 | $226.92 | 5 | Janssen Biotech, Inc. ($99.95) |
| 2020 | $9,618 | 2 | INTERCEPT PHARMACEUTICALS, INC. ($9,600) |
| 2019 | $96.79 | 6 | Janssen Biotech, Inc. ($40.38) |
| 2018 | $13,490 | 18 | Shire North American Group Inc ($13,317) |
| 2017 | $88.15 | 5 | Janssen Biotech, Inc. ($53.54) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.27 | General |
| 11/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/24/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.04 | General |
| Category: Neuroscience | ||||||
| 04/15/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.35 | General |
| Category: Neuroscience | ||||||
| 01/31/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $24.87 | General |
| 12/19/2023 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/05/2023 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/28/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $39.97 | General |
| Category: Immunology | ||||||
| 09/18/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/21/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Immunology | ||||||
| 08/16/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Immunology | ||||||
| 07/11/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: Immunology | ||||||
| 07/11/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $0.82 | General |
| Category: Immunology | ||||||
| 06/21/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Immunology | ||||||
| 06/13/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.72 | General |
| Category: Neuroscience | ||||||
| 03/28/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: IMMUNOLOGY | ||||||
| 02/13/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $42.63 | General |
| Category: Immunology | ||||||
| 12/12/2022 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 928 | 1,023 | $863,073 | $117,388 |
| 2022 | 27 | 1,126 | 1,244 | $791,051 | $107,851 |
| 2021 | 30 | 1,505 | 1,827 | $864,897 | $145,974 |
| 2020 | 26 | 1,103 | 1,259 | $624,934 | $104,564 |
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 231 | 234 | $360,350 | $30,695 | 8.5% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 13 | 19 | $57,500 | $13,156 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 125 | $43,906 | $13,041 | 29.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 56 | 56 | $87,150 | $12,225 | 14.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 151 | 156 | $152,000 | $12,214 | 8.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 88 | 111 | $27,000 | $8,017 | 29.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 72 | 102 | $30,722 | $7,602 | 24.7% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 12 | 12 | $17,346 | $3,595 | 20.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $9,250 | $3,316 | 35.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 55 | 61 | $11,489 | $2,968 | 25.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $14,775 | $2,938 | 19.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $12,548 | $2,752 | 21.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $9,362 | $2,469 | 26.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 25 | $4,875 | $1,268 | 26.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 18 | 18 | $5,800 | $947.53 | 16.3% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $19,000 | $185.61 | 1.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 209 | 209 | $318,700 | $25,353 | 8.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 146 | 146 | $137,625 | $11,033 | 8.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 95 | 136 | $41,297 | $10,169 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 136 | $30,050 | $9,943 | 33.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 47 | 47 | $73,375 | $9,472 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 92 | $32,694 | $9,359 | 28.6% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2022 | 21 | 21 | $30,840 | $6,015 | 19.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 29 | 29 | $20,118 | $5,369 | 26.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 27 | 28 | $11,400 | $4,207 | 36.9% |
About Dr. Marc Wishingrad, MD
Dr. Marc Wishingrad, MD is a Gastroenterology healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093764359.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Wishingrad, MD has received a total of $24,677 in payments from pharmaceutical and medical device companies, with $224.00 received in 2024. These payments were reported across 93 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,000).
As a Medicare-enrolled provider, Wishingrad has provided services to 4,662 Medicare beneficiaries, totaling 5,353 services with total Medicare billing of $475,777. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Santa Monica, CA
- Active Since 05/06/2006
- Last Updated 11/30/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1093764359
Products in Payments
- STELARA (Biological) $520.40
- XELJANZ (Drug) $243.63
- RINVOQ (Biological) $159.91
- SKYRIZI (Biological) $129.17
- HUMIRA (Biological) $114.23
- ZEPOSIA (Drug) $95.65
- SUTAB (Drug) $71.52
- REMICADE (Biological) $69.60
- Alinia (Drug) $39.39
- RESOLUTION CLIP (Device) $37.48
- AVSOLA (Biological) $34.75
- Humira (Biological) $34.11
- CREON (Drug) $29.22
- CLENPIQ (Drug) $22.66
- LINZESS (Drug) $21.08
- Sucraid (Drug) $20.15
- ENTYVIO (Biological) $19.27
- EVENITY (Biological) $17.02
- VIBERZI (Drug) $15.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Santa Monica
Alireza Sedarat, Md, MD
Gastroenterology — Payments: $104,838
Dr. Rudolph Bedford, M.d, M.D
Gastroenterology — Payments: $17,303
Dr. Lenna Martyak, M.d, M.D
Gastroenterology — Payments: $11,403
Dr. Kamyar Shahedi, M.d, M.D
Gastroenterology — Payments: $8,847
Claudia Sanmiguel, M.d, M.D
Gastroenterology — Payments: $6,321
Charles Frankel, M.d, M.D
Gastroenterology — Payments: $4,737